The deal is poised to expand IM’s ground footprint, enabling coordination with a planned lunar satellite network and broader support across low Earth orbit, lunar orbit, and cislunar space.

IM highlighted NASA’s revised Artemis strategy, noting a potential higher cadence of lunar landers under CLPS and the CS-8 CLPS task order that could involve multiple landers from a single proposal.

Goonhilly sees the merger as a way to scale its deep space capabilities globally and integrate with IM to build a commercial lunar communications network.

Key figures, including Goonhilly’s Kenn Herskind and IM CEO Steve Altemus, emphasized the strategic significance of the acquisition for future lunar missions.

Completion of the deal is anticipated later this year and aims to directly support the next era of lunar exploration, including interoperability with Artemis and international missions.

The broader mission context includes NASA’s Space Reactor 1 Freedom program for a nuclear electric propulsion demonstration in 2028, positioning related hardware as a cornerstone for future Mars exploration.

IM plans to increase lander production leveraging Lanteris Space Systems capabilities to enable multiple landers in 24-month cycles.

CEO Steve Altemus stated the acquisition formalizes a long-standing partnership with Goonhilly and positions IM as the leader of its global ground segment, delivering an integrated space-to-ground network.

Goonhilly’s U.K. presence could help IM pursue European Space Agency contracts and bolster international collaboration.

The deal includes Goonhilly’s 44 antennas and the Goonhilly Lunar and Deep Space facilities, described as potentially the world’s first private deep space communications network.

Intuitive Machines, a US aerospace company, plans to buy the Goonhilly Earth Station in Cornwall for 37 million to boost its deep space communications network, paying with a mix of cash and stock.

The acquisition includes Goonhilly Earth Station Ltd. and its American subsidiary Comsat, with completion expected in the third quarter pending regulatory approvals in the U.S. and U.K.